Connect your AI

Sotera Health SHC Restricted Cash

Restricted Cash at other companies

Charles River LaboratoriesCRL

——

Other financials

Income statement

Revenue$280.0M+10.0%

Gross profit$147.1M+8.6%

Operating income$87.1M-16.2%

Net income$26.6M+301%

EPS (diluted)$0.09+280%

Balance sheet

Cash & equivalents$314.1M+3.2%

Total debt$2.3B-3.2%

Total equity$622.5M+50.3%

Total assets$3.2B+4.5%

Cash flow

Operating cash flow$29.4M-47.0%

CapEx$46.2M+132%

Free cash flow-$16.7M-147%

Valuation

Market cap$4.51B+23.4%

Profitability

Gross margin55.3%+0.1pp

Operating margin27%+0.7pp

Net margin9.9%+7.7pp

FCF margin8.1%—

Returns & leverage

Return on equity22.7%+16.8pp

Debt / equity3.6×-2.0×

Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sotera Health's restricted cash?: Sotera Health (SHC) reported restricted cash of $1.8M in Q1 2026.
How has Sotera Health's restricted cash changed year-over-year?: Sotera Health's restricted cash increased by 6.3% year-over-year, from $1.69M to $1.8M.
What is the long-term trend for Sotera Health's restricted cash?: Over 5 years (2020 to 2025), Sotera Health's restricted cash has grown at a 204.6% compound annual growth rate (CAGR), from $7K to $1.84M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.